Kindstar Globalgene Technology (HKSE:09960) Total Liabilities

: HK$911 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Kindstar Globalgene Technology's Total Liabilities for the quarter that ended in Jun. 2023 was HK$911 Mil.

Kindstar Globalgene Technology's quarterly Total Liabilities increased from Jun. 2022 (HK$710.46 Mil) to Dec. 2022 (HK$973.35 Mil) but then declined from Dec. 2022 (HK$973.35 Mil) to Jun. 2023 (HK$910.76 Mil).

Kindstar Globalgene Technology's annual Total Liabilities declined from Dec. 2020 (HK$4,043.95 Mil) to Dec. 2021 (HK$568.34 Mil) but then increased from Dec. 2021 (HK$568.34 Mil) to Dec. 2022 (HK$973.35 Mil).

Kindstar Globalgene Technology Total Liabilities Historical Data

The historical data trend for Kindstar Globalgene Technology's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

1,628.89

4,043.95

568.34

973.35

846.83

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities						568.34	710.46	973.35	910.76	846.83

Kindstar Globalgene Technology Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kindstar Globalgene Technology's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	962.109	+	(9.897	+	1.339
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	973

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	4160.146	-	3186.801
	=	973

Kindstar Globalgene Technology's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	875.602	+	(33.574	+	1.5870000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	911

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	4127.02	-	3216.257
	=	911

Kindstar Globalgene Technology Total Liabilities Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines